Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addressing Both Naturally Occurring and ACT-induced Plasmodium Reservoirs Using Artemisia Infusions to Accelerate Malaria Elimination and Eradication in Rwanda: A Proof of Concept Randomized Controlled Trial

NCT05801198 is registered in ClinicalTrials.gov with King Faisal Hospital Rwanda as lead sponsor.

NCT NCT05801198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05801198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addressing Both Naturally Occurring and ACT-induced Plasmodium Reservoirs Using Artemisia Infusions to Accelerate Malaria Elimination and Eradication in Rwanda: A Proof of Concept Randomized Controlled Trial
Lead sponsor
King Faisal Hospital Rwanda
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 1, 2024
Completion date
December 31, 2026
Enrollment
125 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malaria,falciparum